[Nutrition management in obese patients with type 2 diabetes mellitus after laparoscopic sleeve gastrectomy]. 2017

Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
Department of Nutrition, Fudan University Pudong Medical Center, Shanghai 201399, China.

OBJECTIVE To explore the value of nutrition management in obese patients with type 2 diabetes mellitus(T2DM) after laparoscopic sleeve gastrectomy(LSG). METHODS Clinical data of 22 obese T2DM patients undergoing LSG from March 2013 to July 2015 in Fudan University Pudong Medical Center were collected. All the patients strictly followed the specialized instruction by nutritionists: diabetic and low calorie diet 3347.2 to 5020.8 kJ (800 to 1200 kcal) per day before the operation; low calorie liquid diet 2510.4 kJ(600 kcal) per day before operation for promoting gastric emptying; fasting diet before postoperative ventilation; clear liquid diet 1673.6 to 2510.4 kJ (400 to 600 kcal) per day after postoperative ventilation (liquid intake >2000 ml); low fat liquid diet 2928.8 to 3765.6 kJ (700 to 900 kcal) per day (protein 60 g per day at least, 2000 ml liquid) 2 weeks after the operation; semi-liquid diet 1 month after operation and gradually normal diet. All the 22 patients were followed up at 1 week, 1, 3, 6 months after operation on time. Changes of body weight, waist circumference, hip circumference, body mass index(BMI), blood glucose indexes induding fasting blood glucose(FBG), 2-hour postparandial blood glucose(PBG), fasting C-peptide, 2-hour postprandial C-peptide, fasting serum inculin(FINS), 2-hour postprandial inculin(INS), HbAlc, blood pressure and blood lipid indexes were observed and analyzed before and 1 week, 1, 3, 6 months after operation. RESULTS The average age of 22 patients (10 men and 12 women) was 38.6 years (18 to 66 years). The duration of diabetes varied from 1 month to 15 years. Comorbidity included 12 patients of high blood pressure, 14 of fatty liver, 1 of coronary heart disease, 1 of gout, 1 of chronic thyroiditis and 1 of menstrual disorder. LSG was performed successfully in all the patients and no severe complications and transference to laparotomy occurred. As compared to pre-operation, at 6 months after operation, the average body weight decreased from (103.9±20.2) kg to (80.9±12.6) kg (t=6.294, P=0.000), waist circumference from (118.6±13.8) cm to (96.4±8.0) cm (t=6.331, P=0.000), hip circumference from (116.9±12.6) cm to (104.0±7.7) cm (t=3.854, P=0.000), BMI from (36.2±5.9) kg/m2 to (27.9±3.5) kg/m2 (t=5.630, P=0.000), showing a decreasing trend over time. There was no underweight patient after 6 months follow-up. As compared to pre-operation, at 6 months after operation, the average FBG reduced from (7.4±1.4) mmol/L to (6.0±0.9) mmol/L (t=3.172, P=0.003), 2 h PBG from (14.1±4.9) mmol/L to (7.5±2.2) mmol/L (t=7.026, P=0.000), FINS from (160.0±71.9) mIU/L to (43.8±20.8) mIU/L (t=7.259, P=0.000), 2-hour postprandial INS from (437.6±261.4) mIU/L to (140.5±104.6) mIU/L (t=5.858, P=0.000), fasting C-peptide from (1.1±0.6) μg/L to (0.7±0.3) μg/L (t=3.560, P=0.000), 2-hour postprandial C-peptide from (2.5±0.9) μg/L to (1.5±0.7) μg/L (t=3.865, P=0.000), HbAlc from (8.0±1.6)% to (5.9±0.6)% (t=5.953, P=0.000), showing a decreasing trend over time except FBG, 2h postprandial C-peptide and HbAlc(all P<0.05). FBG and 2-hour PBG of 16 patients returned to normal 3 months after the operation. Blood pressure and trigly ceride decreased obviously 6 months after operation compared to pre-operation with significant difference(P<0.05). At 6 months after operation, blood pressure of 8 comorbidity patients with high blood pressure became normal (8/12, 66.7%) and of 4 patients improved(4/12, 33.3%); B ultrasound examination revealed normal in 11 comorbidity patients with fatty liver(11/14,78.6%) and improvement in 3 patients (3/14,15.4%). Blood uric acid of the gout patient and the menstruation of the menstrual disorder patient returned to normal 3 months and 1 month after the operation respectively. CONCLUSIONS As for obese patients with T2DM undergoing LSG, reasonable nutrition management is helpful to decrease body weight, and to obtain an ideal improvement of blood glucose and blood lipid levels.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008599 Menstruation Disturbances Variations of MENSTRUATION which may be indicative of disease. Hypomenorrhea,Menstruation Disorders,Menstruation, Retrograde,Polymenorrhea,Irregular Menses,Irregular Menstruation,Menstrual Irregularities,Menstrual Irregularity,Disorder, Menstruation,Disorders, Menstruation,Disturbance, Menstruation,Disturbances, Menstruation,Irregularity, Menstrual,Menses, Irregular,Menstruation Disorder,Menstruation Disturbance,Menstruation, Irregular,Retrograde Menstruation
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001837 Body Weights and Measures Measurements of the height, weight, length, area, etc., of the human and animal body or its parts. Body Measures,Body Measure,Measure, Body,Measures, Body
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide

Related Publications

Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
May 2019, Journal of laparoendoscopic & advanced surgical techniques. Part A,
Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
April 2014, Obesity surgery,
Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
May 2009, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery,
Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
April 2011, Obesity (Silver Spring, Md.),
Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
March 2010, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery,
Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
March 2010, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery,
Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
January 2016, SpringerPlus,
Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
September 2016, Obesity surgery,
Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
March 2021, Scientific reports,
Weihong Tang, and Yuhua Chen, and Meizhen Pan, and Lihua Chen, and Lele Zhang, and Tingfeng Wang, and Xiong Zhang, and Peng Zhang, and Chengzhu Zheng, and Bo Yu
December 2017, Obesity surgery,
Copied contents to your clipboard!